Does EPIRUBICIN Cause Neoplasm progression? 266 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 266 reports of Neoplasm progression have been filed in association with EPIRUBICIN (Ellence). This represents 1.6% of all adverse event reports for EPIRUBICIN.
266
Reports of Neoplasm progression with EPIRUBICIN
1.6%
of all EPIRUBICIN reports
42
Deaths
65
Hospitalizations
How Dangerous Is Neoplasm progression From EPIRUBICIN?
Of the 266 reports, 42 (15.8%) resulted in death, 65 (24.4%) required hospitalization, and 10 (3.8%) were considered life-threatening.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EPIRUBICIN. However, 266 reports have been filed with the FAERS database.
What Other Side Effects Does EPIRUBICIN Cause?
Nausea (1,265)
Vomiting (978)
Myelosuppression (934)
Neutropenia (926)
White blood cell count decreased (873)
Febrile neutropenia (809)
Diarrhoea (749)
Asthenia (732)
Pyrexia (729)
Fatigue (685)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
Which EPIRUBICIN Alternatives Have Lower Neoplasm progression Risk?
EPIRUBICIN vs EPLERENONE
EPIRUBICIN vs EPLONTERSEN
EPIRUBICIN vs EPOETIN ALFA-EPBX
EPIRUBICIN vs EPOGEN
EPIRUBICIN vs EPOPROSTENOL